HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

GRB10 sustains AR activity by interacting with PP2A in prostate cancer cells.

Abstract
Prostate cancer (PCa) progression is driven by androgen receptor (AR) signaling. Unfortunately, androgen-deprivation therapy and the use of even more potent AR pathway inhibitors (ARPIs) cannot bring about a cure. ARPI resistance (ie, castration-resistant PCa, CRPC) will inevitably develop. Previously, we demonstrated that GRB10 is an AR transcriptionally repressed gene that functionally contributes to CRPC development and ARPI resistance. GRB10 expression is elevated prior to CRPC development in our patient-derived xenograft models and is significantly upregulated in clinical CRPC samples. Here, we analyzed transcriptomic data from GRB10 knockdown in PCa cells and found that AR signaling is downregulated. While the mRNA expression of AR target genes decreased upon GRB10 knockdown, AR expression was not affected at the mRNA or protein level. We further found that phosphorylation of AR serine 81 (S81), which is critical for AR transcriptional activity, is decreased by GRB10 knockdown and increased by its overexpression. Luciferase assay using GRB10-knockdown cells also indicate reduced AR activity. Immunoprecipitation coupled with mass spectrometry revealed an interaction between GRB10 and the PP2A complex, which is a known phosphatase of AR. Further validations and analyses showed that GRB10 binds to the PP2Ac catalytic subunit with its PH domain. Mechanistically, GRB10 knockdown increased PP2Ac protein stability, which in turn decreased AR S81 phosphorylation and reduced AR activity. Our findings indicate a reciprocal feedback between GRB10 and AR signaling, implying the importance of GRB10 in PCa progression.
AuthorsJun Hao, Xinpei Ci, Yong Wang, Stephen Yiu Chuen Choi, Sarah E Sullivan, Hui Xue, Rebecca Wu, Xin Dong, Anne M Haegert, Colin C Collins, Dong Lin, Yuzhuo Wang
JournalInternational journal of cancer (Int J Cancer) Vol. 148 Issue 2 Pg. 469-480 (01 15 2021) ISSN: 1097-0215 [Electronic] United States
PMID33038264 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© 2020 Union for International Cancer Control.
Chemical References
  • AR protein, human
  • GRB10 protein, human
  • Receptors, Androgen
  • GRB10 Adaptor Protein
  • Protein Phosphatase 2
Topics
  • Animals
  • Cell Line, Tumor
  • GRB10 Adaptor Protein (genetics, metabolism)
  • Gene Knockdown Techniques
  • HEK293 Cells
  • Heterografts
  • Humans
  • Male
  • Mice
  • Prostatic Neoplasms (genetics, metabolism)
  • Protein Phosphatase 2 (antagonists & inhibitors, metabolism)
  • Receptors, Androgen (metabolism)
  • Signal Transduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: